| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $65.3M | +33.8% |
| R&D Expense | $16.6M | -68.4% |
| SG&A Expense | $23.3M | -29.7% |
| Operating Income | $14.5M | +139.6% |
| Pre-tax Income | $17.8M | +155.8% |
| Income Tax | $0 | — |
| Net Income | $17.8M | +155.8% |
| EPS (Basic) | $2.67 | +155.9% |
| EPS (Diluted) | $2.67 |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.7M | -78.1% |
| Short-term Investments | $34.6M | -58.7% |
| Accounts Receivable | $0 | — |
| Current Assets | $40.8M | -62.1% |
| Total Assets | $41.4M | -65.8% |
| Current Liabilities | $8.4M | -58.9% |
| Total Liabilities | $8.4M | -91.3% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.5M | +3.8% |
| Investing Cash Flow | $49.1M | -8.5% |
| Financing Cash Flow | -$11.9M | — |
| +155.9% |
| Stockholders' Equity |
| $33.0M |
| +34.1% |